Posted:
October 11, 2023 11 a.m.
- This page, Board of Registration in Pharmacy (via Webex) — November 2, 2023, is offered by
- Board of Registration in Pharmacy
Public Meeting Notice
Public Meeting Notice Board of Registration in Pharmacy (via Webex) — November 2, 2023
Overview of Board of Registration in Pharmacy (via Webex) — November 2, 2023
This meeting is open to the public by Webex or telephone.
Join by Webex
-
https://eohhs.webex.com/eohhs/j.php?MTID=m1aee272d1136c95f9428d216b0164403
- Webinar number: 2531 528 9272
- Webinar password: J3pdNCkxu73 (53736259 from phones and video systems)
Join by telephone
- +1-617-315-0704 United States Toll (Boston)
- +1-650-479-3208 United States Toll
- Access Code: 253 152 89272
Agenda
|
Time |
# |
Item |
||||||||||||||||||||||||||||||||||||||||||||||||
|
8:00 |
I |
CALL TO ORDER |
||||||||||||||||||||||||||||||||||||||||||||||||
|
8:02 |
II |
APPROVAL OF AGENDA |
||||||||||||||||||||||||||||||||||||||||||||||||
|
8:05 |
III |
APPROVAL OF BOARD MINUTES
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
8:10 |
IV |
REPORTS
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
8:15 |
V |
FLEX
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
9:00 |
VI |
APPLICATIONS
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
9:20 |
VII |
POLICIES Policy 14-02: Board Delegated Review (BDR): The "unknown loss protocol" was removed from the policy since the Board voted for a new "controlled substance loss protocol" at the October meeting. Also added was the ability for BDR to issue a reprimand for the loss of less than #100 units of a Schedule II controlled substance. Policy 2021-04: Continuing Education (CE) Requirements for Pharmacists: Details for the required pain management training for CDTM pharmacists was added to the CE policy. With this addition, we request that the advisory titled "Pain Management Training for CDTM Pharmacists" be rescinded. Policy 2023-01: Compliance Packaging and Reusable Dose Planners Th change to this policy allows Schedule II and III maintenance medications to be placed in multi-drug-single-dose compliance packages. |
||||||||||||||||||||||||||||||||||||||||||||||||
|
9:30 |
VIII |
RECONSIDERATION
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
9:45 |
IX |
FILE REVIEW
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
FILE REVIEW
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
11:30 |
XV |
EXECUTIVE SESSION The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant. The |
||||||||||||||||||||||||||||||||||||||||||||||||
|
12:00 |
LUNCH BREAK |
|||||||||||||||||||||||||||||||||||||||||||||||||
|
2:00 |
XI |
M.G.L. c. 112, § 65C SESSION |
||||||||||||||||||||||||||||||||||||||||||||||||
|
4:00 |
XII |
ADJOURNMENT |